UBS Group AG - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,114,369
-44.1%
102,739
+27.8%
0.00%0.0%
Q2 2023$3,779,515
+12.8%
80,381
+0.6%
0.00%0.0%
Q1 2023$3,351,891
-13.7%
79,883
-21.5%
0.00%0.0%
Q4 2022$3,881,851
+384.6%
101,779
+397.2%
0.00%
Q3 2022$801,000
-66.8%
20,469
-72.6%
0.00%
-100.0%
Q2 2022$2,415,000
-44.9%
74,761
-43.6%
0.00%0.0%
Q1 2022$4,385,000
-23.2%
132,478
-1.3%
0.00%
-50.0%
Q4 2021$5,707,000
+31.4%
134,169
+36.9%
0.00%
+100.0%
Q3 2021$4,342,000
+181.9%
98,000
+261.5%
0.00%
Q2 2021$1,540,000
-35.4%
27,113
-14.9%
0.00%
-100.0%
Q1 2021$2,384,000
+140.1%
31,855
+177.6%
0.00%
Q4 2020$993,000
-25.7%
11,477
-47.5%
0.00%
-100.0%
Q3 2020$1,336,000
-46.9%
21,867
-63.9%
0.00%0.0%
Q2 2020$2,517,000
+499.3%
60,527
+314.8%
0.00%
Q1 2020$420,000
-48.1%
14,593
+30.0%
0.00%
Q4 2019$810,000
-66.4%
11,224
-34.7%
0.00%
-100.0%
Q3 2019$2,412,000
-51.7%
17,194
-37.0%
0.00%
-50.0%
Q2 2019$4,995,000
+1.2%
27,281
-12.1%
0.00%0.0%
Q1 2019$4,935,000
+10.1%
31,032
-33.7%
0.00%0.0%
Q4 2018$4,484,000
+58.1%
46,803
+133.1%
0.00%
+100.0%
Q3 2018$2,836,000
-14.1%
20,077
-4.8%
0.00%0.0%
Q2 2018$3,302,000
-12.8%
21,093
-10.2%
0.00%
-50.0%
Q1 2018$3,785,000
+235.3%
23,493
+242.6%
0.00%
Q4 2017$1,129,000
-69.6%
6,857
-88.5%
0.00%
-100.0%
Q3 2017$3,710,000
+290.5%
59,564
+399.2%
0.00%
Q2 2017$950,000
-35.6%
11,931
-42.5%
0.00%
-100.0%
Q1 2017$1,475,000
-11.0%
20,741
-36.1%
0.00%0.0%
Q4 2016$1,657,000
-79.5%
32,456
-81.5%
0.00%
-80.0%
Q3 2016$8,071,000
+1458.1%
175,262
+920.5%
0.01%
Q2 2016$518,000
+793.1%
17,174
+850.9%
0.00%
Q1 2016$58,000
-96.7%
1,806
-94.0%
0.00%
-100.0%
Q4 2015$1,753,000
+13384.6%
30,074
+9924.7%
0.00%
Q3 2015$13,000
-45.8%
300
-8.8%
0.00%
Q2 2015$24,000
+60.0%
329
+9.7%
0.00%
Q1 2015$15,000
-34.8%
300
-53.2%
0.00%
Q4 2014$23,0006410.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders